Ethyl 4-[2-(6-methyl-3-pyridyloxy)hexyloxy]benzoate (1) and ethyl 4-(2-phenoxyhexyloxy)benzoate (2), which induce precocious metamorphosis in larvae of Bombyx mori, a clear sign of juvenile hormone (JH) deficiency, showed JH activity when topically applied to allatectomized 4th instar larvae of B. mori. Compounds 1 and 2 induced precocious metamorphosis with doses at which they were effective as JH agonists.
Since the juvenile hormone (JH) is involved in a wide range of physiological processes in both developing and mature insects, 1) an anti-JH agent, which chemically blocks the functioning of the JH control system, could be an effective probe for studies on insect endocrinology as well as a potential insect growth regulator. 2) We have recently reported ethyl 4-[2-(6-methyl-3-pyridyloxy)-hexyloxy]benzoate (1) 3) and ethyl 4-(2-phenoxyhexyloxy)benzoate (2) 4) as novel anti-JH agents (Fig. 1 ). These compounds induced precocious metamorphosis in larvae of the silkworm, Bombyx mori, a clear sign of JH deficiency, and their activity could be completely counteracted by the simultaneous application of methoprene, a JH agonist. Compounds 1 and 2 were found by modifying the structure of ethyl 4-[2-(tert-butylcarbonyloxy)butyloxy]benzoate (ETB). ETB is known to show anti-JH activity as well as JH activity toward the tobacco hornworm, Manduca sexta, 5) and B. mori, 6) depending on the dose applied; low doses of ETB induced precocious metamorphosis, but at higher doses, this precocious metamorphosis-inducing activity disappeared and instead, JH activity was observed. Riddiford et al. have reported that ETB acted as a partial antagonist in the Manduca epidermis at the target-tissue level. 7) As previously reported, 3, 4) in our bioassay using 24-hr-old 3rd instar larvae of B. mori, ETB at 1 mg induced precocious pupation in only 10% and no activity was observed at higher doses of 10 mg and 40 mg, while compounds 1 and 2 induced precocious metamorphosis even at high doses. ETB clearly acts as a JH agonist to counteract the effect of allatectomy, the induction of precocious metamorphosis, in a dose-dependent manner. 6) To determine whether compounds 1 and 2 as well as ETB had JH activity, we tested these compounds on allatectomized 4th instar larvae of B. mori.
B. mori (Shunrei x Shougetsu strain) larvae were reared on an artificial diet as previously described. 8) Twenty-four hours after the 3rd molt, the corpora allata were extirpated with fine forceps under a binocular microscope as described by Ohtaki et al. 9) Test compounds in an acetone solution (14 ml/larva) were each applied topically to the dorsal abdomen of the larvae within 1 hour after the allatectomy. JH activity was evaluated by the molting into normal 5th instar larvae. Table 1 shows the effects of methoprene, ETB, 1 and 2 against the allatectomized 4th instar larvae. All of the allatectomized and acetone-treated control larvae underwent precocious metamorphosis. ETB as well as methoprene prevented such precocious metamorphosis at 1 mg so that all the treated larvae molted into 5th instar larvae. Compounds 1 and 2 did not have any JH activity at 1 mg each, however, at higher doses of 10 mg and 40 mg, they showed obvious JH activity, indicating that 1 and 2 acted at the JH target site. It is noteworthy that 1 and 2 as well as ETB induced precocious metamorphosis with doses at which they were effective as JH agonists.
It is not clear why ETB having JH activity was only effective in inducing precocious metamorphosis at low doses. Methoprene, which is a highly potent JH analog, showed no anti-JH activity in a wide range of doses (data not shown). Although numerous compounds such as aryl geranyl ethers, alkyl (2E,4E)-3,7,11-trimethyl-2,4-dodecadienoates and 4-phenoxyphenoxy analogs have been found to exhibit potent JH activity, 10) no data on the anti-JH activity of these JH analogs have so far been presented. ETB was the only compound showing both JH and anti-JH activity. We have demonstrated in the present study that compounds 1 and 2, which had less JH activity than ETB, were more potent than ETB as anti-JH agents. To develop a genuine anti-JH agent, further studies on the structure-activity relationships of this series of compounds are in progress. 
